OOIR: Observatory of International Research

Papers

(The H4-Index of Nature Reviews Cardiology is 69. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
LIPC variant in combined hypocholesterolaemia	525
Antibody treatment to deplete transthyretin amyloid deposits in the heart	500
Sacubitril–valsartan shows benefit in heart failure with ejection fraction of >40%	471
Intravascular imaging improves outcomes	444
Bariatric metabolic surgery more effective than GLP1R agonists in preventing congestive HF	440
Accelerated reduction in global cardiovascular disease is essential to achieve the Sustainable Development Goals	398
The City Heartbeat Index as a benchmarking tool for urban cardiovascular health	356
Screening for Helicobacter pylori infection in patients with cardiovascular and gastrointestinal disease	351
Optimizing cardiovascular pharmacotherapy in older adults with frailty	329
Genetics and mechanisms of thoracic aortic disease	297
Changing epidemiology of congenital heart disease: effect on outcomes and quality of care in adults	285
Takotsubo syndrome: pathophysiological insights and innovations in patient care	273
Aggregation of big tau disrupts microtubules and causes diastolic dysfunction	269
Alternative defibrillation strategies improve outcomes	265
Detection of subclinical hypertrophic cardiomyopathy	254
Defining iron deficiency in patients with heart failure	251
Drug-coated balloon angioplasty for coronary and peripheral artery disease: latest evidence and clinical indications	248
Maternal cardiovascular disorders before and during pregnancy and offspring cardiovascular risk across the life course	246
Base editing and silencing of PCSK9 shows clinical promise in humans	237
HFpEF and MASLD: converging mechanisms and clinical implications	229
European guidelines for hypertension in 2024: a comparison of key recommendations for clinical practice	209
Think Aorta: aortic dissection awareness and perspectives from the patient	192
Factor XI inhibitors in patients with cardiovascular disease and a high risk of bleeding: a cautionary tale	189
Hallmarks of cardiovascular ageing	185
A fatty acid from mother’s milk drives cardiomyocyte maturation in newborn mice	175

Preparticipation screening reduces SCD in young athletes	174
Decongestion in heart failure: medical and device therapies	158
No benefit of apoA-I infusion after myocardial infarction	154
Low-dose IL-2 therapy reduces arterial inflammation in acute coronary syndromes	154
Identifying leukocyte phenotypes by scRNA-seq to predict cardiovascular risk	149
Catheter ablation improves outcomes in patients with AF and end-stage HF	146
Increased degradation of desmosomal proteins in ACM	145
LDL-cholesterol lowering with obicetrapib	140
Colchicine in acute coronary syndromes: the present and the possible future	138
CSDE1 regulates LDL receptor levels	132
Reactive oxygen species in hypertension	130
Extracellular matrix in vascular homeostasis and disease	128
Graded exercise therapy should not be recommended for patients with post-exertional malaise	128
Targeting immune cell recruitment in atherosclerosis	124
Cardiac lymphatic dysfunction and repair in cardiovascular disease	124
Tailored therapeutics for cardiomyopathies	123
The oral microbiome in the pathophysiology of cardiovascular disease	122
Donor macrophages influence rejection of transplanted hearts	121
Modelling pre-eclampsia and its cardiovascular effects	119
Cardiac sarcomere turnover by unidirectional replacement of proteins	118
Unlocking excellence in health care: the power of inclusive and sensitive language in medicine	115
Bempedoic acid prevents cardiovascular events in statin-intolerant patients	114
Semaglutide is beneficial in patients with HFpEF and obesity	113
Calculation methods for LDL cholesterol are evolving tools for accuracy in lipidology	111
Evidence does not support the reduction of added sugar intake from all food sources	108
Reply to ‘Graded exercise therapy should not be recommended for patients with post-exertional malaise’	102
RNA interference lowers triglyceride levels	101
Not a spectator sport: improving participation of Black patients in cardiovascular clinical trials	98
Local calcium dynamics and signalling in cardiomyocytes	97
Mitochondrial uncoupling therapy reduces established atherosclerosis in mice	92
Promising novel siRNA for the treatment of hypertension	90
An epigenome editing approach induces durable silencing of Pcsk9	84
Global epidemiology of heart failure	84
Author Correction: The contribution of amyloid deposition in the aortic valve to calcification and aortic stenosis	83
The role of the molecular autopsy in sudden cardiac death in young individuals	83
Simvastatin protects against endothelial dysfunction via epigenetic mechanisms	83
Tricuspid valve disease: updates on diagnostic imaging and intervention	82
Development of a miniature, bioresorbable, light-activated pacemaker	79
The gut metabolite imidazole propionate is a potential biomarker of and therapeutic target for atherosclerosis	77
Digital screening and decision-support tools in equitable preventive cardiology	76
Heart transplantation: advances in expanding the donor pool and xenotransplantation	73
Computational modelling of cardiovascular pathophysiology to risk stratify commercial spaceflight	72
Clonal haematopoiesis in cardiovascular disease: prognostic role and novel therapeutic target	71
Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology	70
Efferocytosis in atherosclerosis	69
Low alcohol intake might lower CVD risk by reducing stress-related brain activity	69